2026-05-14T15:26:37-05:00 2025-06-30 133628255 CONDON O'MEARA MCGINTY & DONNELLY LLP ONE BATTERY PARK PLAZA 7TH FL NEW YORK NY 10004 990 2024-07-01 202905531 NEW YORK STEM CELL FOUNDATION INC NEWY 2123657428 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 JEFF WALLERSTEIN CHIEF FINANCIAL & OPERATING OFFICER 2123657428 2026-05-14 1 0 ALEXANDER LAZZARUOLO P01775353 2126617777 2024 2025-03-06 01:10:19Z JEFF WALLERSTEIN 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 26602392 0 X WWW.NYSCF.ORG X 2005 NY SEE SCHEDULE O. 13 13 155 13 0 0 23317267 26188915 0 0 104026 23048 -358230 -305563 23063063 25906400 8505691 6699139 0 0 18306600 16284768 0 0 1706348 17595305 17371666 44407596 40355573 -21344533 -14449173 82924502 61911047 69999817 63629611 12924685 -1718564 X SEE SCHEDULE O. 0 0 36204368 6699139 SEE SCHEDULE O. 36204368 1 1 0 1 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 1 0 0 0 0 1 0 0 0 1 1 0 0 0 1 47 0 1 155 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 13 13 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA NY X NEW YORK STEM CELL FOUNDATION 2123657428 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 ROY GERONEMUS CHAIRMAN & DIRECTOR 6.00 X X 0 0 0 MARGO ALEXANDER FORMER TREASURER & DIRECTOR 6.00 X X 0 0 0 DERRICK ROSSI DIRECTOR 3.00 X 0 0 0 KAREN BURKE DIRECTOR 3.00 X 0 0 0 FRANCESCO CLARK DIRECTOR 3.00 X 0 0 0 RICHARD J MASSEY DIRECTOR 3.00 X 0 0 0 PAUL GOLDBERGER DIRECTOR 3.00 X 0 0 0 PAUL M MEISTER DIRECTOR 3.00 X 0 0 0 SIDDHARTHA MUKHERJEE DIRECTOR 3.00 X 0 0 0 STEPHEN M ROSS DIRECTOR 3.00 X 0 0 0 KAY UNGER DIRECTOR 3.00 X 0 0 0 STEPHEN M SCHERR DIRECTOR 3.00 X 0 0 0 CLYDE WILLIAMS DIRECTOR 3.00 X 0 0 0 MARILYN BRESLOW DIRECTOR 3.00 X 0 0 0 JENNIFER RAAB PRESIDENT AND CEO 40.00 X 698208 0 13944 JEFFREY WALLERSTEIN CFO & COO 40.00 X 578750 0 30460 DANIEL PAULL VICE PRESIDENT, STEM CELL 40.00 X 397722 0 30342 CHRISTINE LIN CHIEF ADVANCEMENT OFFICER 40.00 X 318850 0 12761 FREDERICK MONSMA SENIOR VICE PRESIDENT, SCI 40.00 X 307849 0 22836 DAVID MCKEON CHIEF OF STAFF 40.00 X 290710 0 11061 HOWARD KIM VICE PRESIDENT, CELL THEORY 40.00 X 286400 0 28129 2878489 0 149533 44 0 1 0 GOODWIN PROCTER LLC 100 NORTHERN AVE BOSTON MA 02210 LEGAL 326047 JAROS BAUM & BOLLE 80 PINE STREET NEW YORK NY 10005 CONSTRUCTION CONSULTANT 205734 ENNEAD ARCHITECH LLC 1 WORLD TRADE CENTER 40TH FL NEW YORK NY 10007 CONSTRUCTION CONSULTANT 115920 BRUCE A GOLDSMITH 7 ROSEDALE WAY PENNINGTON NJ 08534 CONSULTANT 112000 4 1850776 1082241 23255898 210837 26188915 29162 29162 15955 15955 204723 210837 -6114 -6114 -6114 150300 1850776 485155 -334855 -334855 OTHER 900099 13337 13337 13337 25906400 0 0 -282515 5799139 5799139 900000 900000 1340801 784907 342149 213745 12249453 10912212 635155 702086 227098 202613 11408 13077 1509918 1335000 63998 110920 957498 833024 62237 62237 1245195 912441 332754 32056 656 31400 92900 92900 695918 635417 71101 -10600 453178 329883 73060 50235 4823010 4319666 256719 246625 22552 5590 1663 15299 201913 176919 6172 18822 849855 673765 138581 37509 2068592 1895962 106547 66083 397528 345849 31803 19876 LABORATORY EXPENSES 4626245 4626245 BAD DEBT 1420793 1320793 100000 OTHER 309794 139663 163422 6709 DUES & SUBSCRIPTIONS 50804 15088 16244 19472 81333 39536 7544 34253 40355573 36204368 2444857 1706348 1000 893 4354174 1537842 22106299 11825693 904684 269987 44705218 25779600 20882307 18925618 34676038 29351014 82924502 61911047 6130959 8888233 8499523 2520135 342575 299497 1599383 4357418 3833333 50669342 46489030 69999817 63629611 X -4791733 -11164685 17716418 9446121 12924685 -1718564 82924502 61911047 X -14449173 9128 -203204 X X 0 1 X 1 0 X 41698818 34249618 30384933 23317267 26188915 155839551 41698818 34249618 30384933 23317267 26188915 155839551 46979482 108860069 354747 3071546 78794 114272 45117 3664476 1536965 191106 15111 13337 1756519 161260546 0.67510 0.58510 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 92900 92900 40262673 40355573 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 75150 92900 168050 250000 250000 250000 250000 1000000 1500000 27953793 11397881 16555912 14925787 14381719 544068 1825638 1825638 18925618 INTEREST RATE SWAP ASSET 30043 RIGHT-OF-USE ASSET, NET OPERATING LEASE (SEE SUPPLEMENTAL INFO IN PART XIII) 29320971 29351014 CAPITAL LEASE PAYABLE 442053 LANDLORD PAYABLE 338229 OPERATING LEASE LIABILITY (SEE PART XIII SUPPLEMENTAL) 39708748 LINE OF CREDIT 6000000 46489030 X 27237141 9128 1039662 485155 1533945 25703196 203204 203204 25906400 41880390 1039662 485155 1524817 40355573 0 40355573 PART X, LINE 2: NYSCF IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, RELATING TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. BECAUSE OF NYSCF'S GENERAL TAX-EXEMPT STATUS, THE ADOPTION OF ASC TOPIC 740-10-05 HAS NOT HAD, AND IS NOT EXPECTED TO HAVE, A MATERIAL IMPACT ON NYSCF'S FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 485,155. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTEREST RATE SWAP 52,904. GROSS UP FUNDRAISING REVENUE 150,300. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 485,155. PART IX AND X OTHER ASSETS AND LIABILITIES EFFECTIVE JULY 1, 2022, NYSCF ADOPTED THE NEW FASB ASC 842, LEASES. THE NEW STANDARD ESTABLISHES A RIGHT OF USE ("ROU") MODEL THAT REQUIRES A LESSEE TO RECORD A ROU ASSET, WHICH REPRESENTS THE RIGHT TO USE A RESPECTIVE ASSET FOR THE LEASE TERM, AND A LEASE LIABILITY ON THE STATEMENT OF FINANCIAL POSITION AT THE PRESENT VALUE OF THE REMAINING FUTURE PAYMENTS DUE UNDER THE LEASE. AS OF JUNE 30, 2024, THIS ADJUSTMENT INCREASED THE NET ROU ASSET BY $29,320,971 AND THE NET OPERATING LEASE LIABILITY BY $39,708,748. 1 EUROPE 0 0 GRANTMAKING GRANTS 600000 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTMAKING GRANTS 300000 0 0 0 0 0 0 900000 0 900000 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM GRANTS 600000 WIRE 0 FMV NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES GRANT 300000 WIRE 0 FMV 0 0 0 0 0 0 PART I, LINE 2: NYSCF WILL CONTACT BOTH THE INDIVIDUAL AND THE INSTITUTION IN WHICH THE GRANT/FELLOWSHIP WILL BE HELD. IN ACCEPTING THE FUNDS, THE GRANTEE/FELLOW MUST AGREE TO THE TERMS AND CONDITIONS SET FORTH BY NYSCF AND ACKNOWLEDGE THAT WHILE NYSCF IS PROVIDING SUPPORT FOR THIS PROJECT, SOLE RESPONSIBILITY FOR THE SUPERVISION, DIRECTION AND CONTROL OF THE CONDUCT OF THE PROJECT LIES WITH THE GRANTEE/FELLOW. THE GRANTEE/FELLOW IS ALSO RESPONSIBLE FOR TRANSMITTING A COPY OF THE NOTIFICATION FROM NYSCF TO THEIR FACULTY SPONSOR AND HOST INSTITUTION FOR SIGNATURES. IF THE GRANT OR FELLOWSHIP IS TERMINATED PREMATURELY FOR ANY REASON OR IF THE FELLOW WISHES TO AMEND THE PROJECT, NYSCF MUST BE NOTIFIED IMMEDIATELY. GALA 2001076 1850776 150300 168231 150300 166624 2001076 1850776 150300 168231 150300 166624 485155 -334855 1 UNIVERSITY OF WISCONSIN 500 LINCOLN DR MADISON WI 53706 396006492 501(C)(3) 61000 0 FELLOWSHIP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 1 GUSTAVE L LEVY PL NEW YORK NY 10029 136171197 501(C)(3) 260835 0 FELLOWSHIP & GRANT YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 501(C)(3) 299604 0 GRANT UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVE NE SEATTLE WA 98195 943079432 501(C)(3) 300000 0 GRANT UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL PO BOX BOX 841765 DALLAS TX 75284 752556007 501(C)(3) 300000 0 GRANT THE BRIGHAM AND WOMEN'S HOSPITAL 75 FRANCIS STREET BOSTON MA 02115 042312909 501(C)(3) 300000 0 GRANT NEW YORK UNIVERSITY 25 WEST 4TH ST ROOM 405 NEW YORK NY 10012 135562308 501(C)(3) 300000 0 GRANT MONELL CHEMICAL SENSES CENTER 3500 MARKET ST PHILADELPHIA PA 19104 232020897 501(C)(3) 300000 0 GRANT DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02215 042263040 501(C)(3) 300000 0 GRANT BROAD INSTITUTE 415 MAIN STREET CAMBRIDGE MA 02142 263428781 501(C)(3) 300000 0 GRANT MEMORIAL SLOAN-KETTERING CANCER CENTER 1275 YORK AVE NEW YORK NY 10065 131924236 501(C)(3) 300000 0 GRANT BOSTON CHILDREN'S HOSPITAL 300 LONGWOOD AVENUE BOSTON MA 02115 042774441 501(C)(3) 300000 0 GRANT MASSACHUSETTS GENERAL HOSPITAL 185 CAMBRIDGE ST BOSTON MA 02114 041564655 501(C)(3) 361000 0 FELLOWSHIP & GRANT HARVARD COLLEGE PO BOX 415649 BOSTON MA 02241 042103580 501(C)(3) 361000 0 FELLOWSHIP & GRANT COLUMBIA UNIVERSITY 615 WEST 131 STREET 6TH FL NEW YORK NY 10027 135598093 501(C)(3) 361000 0 FELLOWSHIP & GRANT PRINCETON UNIVERSITY NEW SOUTH BUILDING FOURTH FL PRINCETON NJ 08545 210634501 501(C)(3) 600000 0 FELLOWSHIP & GRANT UNIVERSITY OF CALIFORNIA SAN FRANCISCO PO BOX 748872 LOS ANGELES CA 74872 943067788 501(C)(3) 600000 0 GRANT NEW YORK STEM CELL FOUNDATION 619 W 54TH STREET NEW YORK NY 10019 202905531 501(C)(3) 194700 0 FELLOWSHIPS 18 PART I, LINE 2: NYSCF WILL CONTACT BOTH THE INDIVIDUAL AND THE INSTITUTION IN WHICH THE GRANT/FELLOWSHIP WILL BE HELD. IN ACCEPTING THE FUNDS, THE GRANTEE/FELLOW MUST AGREE TO THE TERMS AND CONDITIONS SET FORTH BY NYSCF AND ACKNOWLEDGE THAT WHILE NYSCF IS PROVIDING SUPPORT FOR THIS PROJECT, SOLE RESPONSIBILITY FOR THE SUPERVISION, DIRECTION AND CONTROL OF THE CONDUCT OF THE PROJECT LIES WITH THE GRANTEE/FELLOW. THE GRANTEE/FELLOW IS ALSO RESPONSIBLE FOR TRANSMITTING A COPY OF THE NOTIFICATION FROM NYSCF TO THEIR FACULTY SPONSOR AND HOST INSTITUTION FOR SIGNATURES. IF THE GRANT OR FELLOWSHIP IS TERMINATED PREMATURELY FOR ANY REASON OR IF THE FELLOW WISHES TO AMEND THE PROJECT, NYSCF MUST BE NOTIFIED IMMEDIATELY. X X X X X 0 0 0 0 0 0 0 0 0 JENNIFER RAAB PRESIDENT AND CEO 698208 0 0 0 0 0 12938 0 1006 0 712152 0 0 0 JEFFREY WALLERSTEIN CFO & COO 578750 0 0 0 0 0 17250 0 13210 0 609210 0 0 0 DANIEL PAULL VICE PRESIDENT, STEM CELL 397722 0 0 0 0 0 12938 0 17404 0 428064 0 0 0 CHRISTINE LIN CHIEF ADVANCEMENT OFFICER 318850 0 0 0 0 0 12141 0 620 0 331611 0 0 0 FREDERICK MONSMA SENIOR VICE PRESIDENT, SCI 307849 0 0 0 0 0 11731 0 11105 0 330685 0 0 0 HOWARD KIM VICE PRESIDENT, CELL THEORY 286400 0 0 0 0 0 10725 0 17404 0 314529 0 0 0 DAVID MCKEON CHIEF OF STAFF 290710 0 0 0 0 0 11061 0 0 0 301771 0 0 0 ROY GERONEMUS MD DIRECTOR WORKING CAPITAL X 99383 99383 0 1 1 KAY UNGER DIRECTOR WORKING CAPITAL X 500000 500000 0 1 1 PAUL MEISTER DIRECTOR WORKING CAPITAL X 150000 150000 0 1 1 KAREN ELIZABETH BURKE MD DIRECTOR WORKING CAPITAL X 50000 50000 0 1 1 STEPHEN SCHERR DIRECTOR WORKING CAPITAL X 150000 150000 0 1 1 RICHARD MASSEY DIRECTOR WORKING CAPITAL X 50000 50000 0 1 1 STEPHEN ROSS DIRECTOR WORKING CAPITAL X 350000 350000 0 1 1 DERRICK ROSSI DIRECTOR WORKING CAPITAL X 250000 250000 0 1 1 1599383 X 8 210837 FMV 0 1 0 PART I - LINE 1 AND PART III - LINE 1 THE NEW YORK STEM CELL FOUNDATION ("NYSCF") IS A NOT-FOR-PROFIT ORGANIZATION THAT WAS INCORPORATED IN THE STATE OF NEW YORK ON MAY 19, 2005. NYSCF'S MISSION IS TO ACCELERATE CURES FOR THE MAJOR DISEASES OF OUR TIME THROUGH STEM CELL RESEARCH. NYSCF PROGRAMS INCLUDE: 1) NYSCF RESEARCH - SUPPORTING AND ENABLING THE UNRESTRICTED PURSUIT OF THE MOST ADVANCED STEM CELL RESEARCH, BOTH IN OUR OWN LABORATORY AND THROUGH COLLABORATIONS WITH MAJOR MEDICAL RESEARCH INSTITUTIONS; 2) NYSCF FELLOWSHIP AND INNOVATOR PROGRAMS - SUPPORTING AND TRAINING THE NEXT GENERATION OF SCIENTISTS, BOTH AT THE POST-DOCTORAL LEVEL AS FELLOWS, AND AS INVESTIGATORS PURSUING INNOVATIVE WORK THAT TRANSLATES RESEARCH INTO CURES; 3) NYSCF CONFERENCE AND SYMPOSIA - CONVENING THE PRE-EMINENT ANNUAL TRANSLATIONAL STEM CELL RESEARCH CONFERENCE AND AN ON-GOING SERIES OF PROGRAMS FOR SCIENTISTS, POLICYMAKERS AND THE PUBLIC. PART III - LINE 4A NYSCF RESEARCH - SUPPORTING AND ENABLING THE UNRESTRICTED PURSUIT OF THE MOST ADVANCED STEM CELL RESEARCH, BOTH IN OUR OWN LABORATORY AND THROUGH COLLABORATIONS WITH MAJOR MEDICAL RESEARCH INSTITUTIONS. NYSCF FELLOWSHIP AND INNOVATOR PROGRAMS - SUPPORTING AND TRAINING THE NEXT GENERATION OF SCIENTISTS, BOTH AT THE POST-DOCTORAL LEVEL AS FELLOWS, AND AS INVESTIGATORS PURSUING INNOVATIVE WORK THAT TRANSLATES RESEARCH INTO CURES. NYSCF CONFERENCE AND SYMPOSIA - CONVENING THE PRE-EMINENT ANNUAL TRANSLATIONAL STEM CELL RESEARCH CONFERENCE AND AN ON-GOING SERIES OF PROGRAMS FOR SCIENTISTS, POLICYMAKERS AND THE PUBLIC. FORM 990, PART VI, SECTION A, LINE 2 JEFF WALLERSTEIN, CHIEF FINANCIAL & OPERATING OFFICER IS THE BROTHER-IN-LAW OF STEPHEN SCHERR, DIRECTOR. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS DISTRIBUTED TO THE ENTIRE BOARD OF DIRECTORS FOR THEIR REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS DISTRIBUTED ANNUALLY FOR REVIEW AND SIGNATURE. FORM 990, PART VI, SECTION B, LINE 15 COMPENSATION IS DETERMINED BY REVIEWING COMPARABLE ORGANIZATIONS' FORM 990, ENGAGING AN INDEPENDENT COMPENSATION CONSULTANT TO PREPARE AN ANALYSIS AND REPORT ABOUT THE CEO AND OTHER KEY EMPLOYEE'S COMPENSATION. THESE MATERIALS ARE PRESENTED TO THE ORGANIZATION'S COMPENSATION COMMITTEE, WHICH REPORTS TO THE FULL BOARD. FORM 990, PART VI, SECTION C, LINE 19 NYSCF MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: INTEREST RATE SWAP -52,904. GROSS UP FUNDRAISING REVENUE -150,300. FORM 990. PART XII, LINE 2C. THE PROCESS HAS NOT BEEN CHANGED FROM THE PRIOR YEAR. CELLRAY LLC 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 833338908 RESEARCH DE 0 0 NYSCF CELLRAY TECHNOLOGIES INC 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 455639489 RESEARCH DE NYSCF C 1.00000 0 CELLRAY GLOBAL INC 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 463664876 RESEARCH DE NYSCF C 1.00000 0 FOUNDATION CELL THERAPEUTICS 619 WEST 54TH STREET 3RD FL NEW YORK NY 10019 371905708 RESEARCH DE NYSCF C 1.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0